| 2024/08/30 17:35:07 | |
|---|---|
| Price | |
| 2.09 EUR | |
| Difference | -0.95% (-0.02) |
General attributes
| ISIN | FR0010331421 |
| Symbol | IPH |
| Exchange | Euronext Paris |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 169 EUR |
| Benchmark | CAC 40 INDEX |
Market data
| Bid (Bid size) | 2.085 EUR (1,000) |
| Ask (Ask size) | 2.125 EUR (579) |
| Open | 2.10 EUR |
| High | 2.125 EUR |
| Low | 2.085 EUR |
| Close (prev. day) | 2.11 EUR |
| VWAP | 2.106828 EUR |
| Volume (pcs) | 37,269 |
| Trading volume | 78,519.00 |
| Number of trades | 141 |
| Last size | 17 |
Futures and Options
| Related Futures | 0 |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/08/30 17:35:07 | |
|---|---|
| Price | |
| 2.09 EUR | |
| Difference | -0.95% (-0.02) |
General attributes
| ISIN | FR0010331421 |
| Symbol | IPH |
| Exchange | Euronext Paris |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 169 EUR |
| Benchmark | CAC 40 INDEX |
Market data
| Bid (Bid size) | 2.085 EUR (1,000) |
| Ask (Ask size) | 2.125 EUR (579) |
| Open | 2.10 EUR |
| High | 2.125 EUR |
| Low | 2.085 EUR |
| Close (prev. day) | 2.11 EUR |
| VWAP | 2.106828 EUR |
| Volume (pcs) | 37,269 |
| Trading volume | 78,519.00 |
| Number of trades | 141 |
| Last size | 17 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -4.35% | -26.54% | -32.14% |
| Perf (abs.) | -0.10 | -0.76 | -0.99 |
| Beta | 0.98 | 0.93 | 0.95 |
| Volatility | 36.62 | 43.17 | 56.69 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 2.11 EUR (23,669) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 2.06 EUR (28,591) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 2.19 EUR (59,951) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2.31 EUR (83,694) |
| YTD High | date | 2.80 EUR (2024/01/04) |
| YTD Low | date | 1.86 EUR (2024/06/28) |
| 52 Weeks High | date | 3.04 EUR (2023/09/04) |
| 52 Weeks Low | date | 1.86 EUR (2024/06/28) |
All listings for INNATE PHARMA SA
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/08/30 | 08:20 | 2.07 EUR | 0.00 | 3 |
| Duesseldorf | 2024/08/30 | 08:11 | 2.085 EUR | 0.00 | 3 |
| Euronext Paris | 2024/08/30 | 17:35 | 2.09 EUR | 0.08 | 141 |
| FINRA other OTC Issues | 2024/08/22 | 19:37 | 2.30 USD | 0.00 | 1 |
| Frankfurt | 2024/08/30 | 08:10 | 2.07 EUR | 0.00 | 2 |
| London Stock Exchange European Trade Reporting | 2024/08/30 | 17:30 | 2.1075 EUR | 0.00 | 2 |
| Munich | 2024/08/30 | 08:20 | 2.075 EUR | 0.00 | 1 |
| Stuttgart | 2024/08/30 | 15:42 | 2.065 EUR | 0.00 | 5 |
| Tradegate | 2024/08/30 | 22:26 | 2.095 EUR | 0.00 | 1 |
Company Profile
| - |
Board of directors
| Irina Staatz-Granzer | Chairman of Supervisory Board |
| Jean-Yves Blay | Member of Supervisory Board |
| Olivier Martinez | Member of Supervisory Board |
| Sally Bennett | Member of Supervisory Board |
| Véronique Chabernaud | Member of Supervisory Board |
| Gilles Brisson | Member of Supervisory Board |
| Pascale Boissel | Member of Supervisory Board |